Document:

Exhibit 4.2

    
      

    

    

    
      	
              NUMBER
                09

            	
               

            	
              600,000
                WARRANTS

            
	 	
               Each
                Warrant Exercisable for One Share of Common
                Stock

            

    

    

    
      	 	
              SEQUIAM
                CORPORATION

              a
                California corporation

            	 
	 	 	
              see
                reverse for 

              certain
                definitions 

            
	 	
              COMMON
                STOCK PURCHASE WARRANTS

            	 

    

    

    

    This
      Certifies that for value received, Lee Harrison Corbin, Attorney-in-Fact for
      the
      Trust Under the Will of John Svenningsen, the registered holder
      (“Holder”),

    

    
      	
              is
                entitled to purchase from Sequiam Corporation, a California corporation
                (the "Company"), one share of Common Stock in the Company for each
                Warrant
                represented by this certificate, at any time during the “Exercise Period”
                (as hereinafter defined) at a purchase price (the "Exercise Price")
                equal
                to $0.33. As used herein, the "Exercise Period" shall mean the period
                beginning on March 24, 2005, and expiring on March 24, 2010. Holder
                will
                not have any rights or privileges of stockholders of the Company
                pursuant
                to the Warrants prior to exercise of the Warrants. The Warrants evidenced
                hereby may be exercised in whole or in part by presentation of this
                Warrant Certificate with the Purchase Form on the reverse side hereof
                fully executed and simultaneous payment of the Warrant Price at the
                principal office of the Company. Payment of the Warrant Price shall
                be
                made at the option of the Holder in cash or by certified check or
                bank
                draft. Upon any partial exercise of the Warrants evidenced hereby,
                there
                shall be countersigned and issued to the Holder

            	 	
              a
                new Warrant Certificate in respect of the Warrants evidenced hereby
                that
                shall not have been exercised. The Holder hereof may be treated by
                the
                Company and all other persons dealing with this Warrant Certificate
                as the
                absolute owner hereof for all purposes and as the person entitled
                to
                exercise the rights represented hereby, any notice to the contrary
                notwithstanding, and until such transfer is on such books, the Company
                may
                treat the Holder as the owner for all purposes. 

               

              This
                warrant is issued pursuant to an assignment by Constellation Biometrics
                Corporation of all of its right, title and interest in and to a warrant
                for like number of shares with an exercise price of $0.33 per share
                issuable to Constellation on March 24, 2005. The exercise price was
                reduced to $0.14 per share effective May 19,
                2005.

            

    

    

    

    
      	
              Dated:
                March 24, 2005

            	
              SEQUIAM
                CORPORATION, a California corporation

            	
            

    

     

    
      	 	
               

            	
               

            
	
              Mark
                Mroczkowski, Secretary

            	
               

            	
              Nicholas
                VandenBrekel, Chief Executive Officer 

            

    

    

    

    SEE
      LEGEND ON REVERSE

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY
      STATE, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR
      OTHERWISE DISPOSED OF EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT
      UNDER THE 1933 ACT AND ANY APPLICABLE STATE LAWS, OR VALID EXCEPTION THERETO,
      (ii) TO THE EXTENT APPLICABLE, IN ACCORDANCE WITH RULE 144 UNDER THE 1933 ACT
      (OR ANY SIMILAR RULE UNDER THE 1933 ACT RELATING TO THE DISPOSITION OF
      SECURITIES), AND (iii) AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO COUNSEL
      TO THE ISSUER, THAT AN EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT AND
      APPLICABLE STATE LAW IS AVAILABLE AND SUCH TRANSFER IS MADE IN ACCORDANCE WITH
      RULE 144.

    

    ELECTION
      TO PURCHASE

    

    The
      undersigned hereby elects irrevocably to exercise _______ of the within
      Warrant(s) and hereby makes payment of $_________ in payment of the Exercise
      Price pursuant hereto. Please issue the Common Stock as to which this Warrant
      is
      exercised in accordance with the instructions given below.

     

    

    Dated:
      ________________, 20 ______  Signature:
      _____________________________________________

    

    

    INSTRUCTIONS
      FOR REGISTRATION OF SHARES

    

    Name
      (print)
      __________________________________________________________________

    

    Address
      (print)
      ________________________________________________________________

    

    

    ASSIGNMENT

    

    FOR
      VALUE
      RECEIVED, ____________________________________ does hereby sell, assign and
      transfer unto ____________________________________________, __________________
      Warrants, evidenced by the within Warrant Certificate, and does hereby
      irrevocably constitute and appoint ______________________________ attorney
      to
      transfer such right on the books of Sequiam Corporation, with full power of
      substitution on the premises.

    

    

    Dated:
      ________________, 20 ______  Signature:
      _____________________________________________

    

    Notice:
      The
      signature of Election to Purchase or Assignment must correspond with the name
      as
      written upon the face of the within Warrant in every particular without
      alteration or enlargement or any change whatsoever.Exhibit 10.1

    
      

    

    Exhibit
      10.1

    

    THIS
      SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
      (THE ?SECURITIES ACT?), OR THE SECURITIES LAWS OF ANY STATE, AND IS BEING
      OFFERED AND SOLD PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS
      OF
      THE SECURITIES ACT AND SUCH LAWS. THIS SECURITY MAY NOT BE SOLD OR TRANSFERRED
      EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT
      OR PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
      THE
      SECURITIES ACT OR SUCH OTHER LAWS.

    

    PROMISSORY
      NOTE

    (Lee
      Harrison Corbin, Attorney-in-Fact For the Trust Under the Will of John
      Svenningsen)

    

    
      	
              $200,000.00

            	
               

            	
              Orlando,
                Florida

            
	 	
            	
              March
                23, 2004 [sic]

            

    

    

    FOR
      VALUE
      RECEIVED, CONSTELLATION BIOMETRICS CORPORATION, a Florida corporation (?
      Constellation ? or ?Maker?), hereby promises to pay to the order of LEE HARRISON
      CORBIN, ATTORNEY-IN-FACT FOR THE TRUST UNDER THE WILL OF JOHN SVENNINGSEN
      (?Holder?), or any subsequent Holder of this Note (the ?Note?) at such location
      as Holder shall designate by written notice to Maker, the principal sum of
      Two
      Hundred Thousand Dollars ($200,000), with interest from the date such principal
      amount was received by Maker until the date paid.

    

    1.    Interest.
      The
      principal balance of this Note outstanding from time to time shall bear interest
      from the date such principal amount was received by Maker at five percent (8%),
      compounded every thirty (30) days, until paid in full. Such interest shall
      be
      calculated on the basis of a three hundred sixty-five (365) day year, actual
      number of days elapsed.

    

    2.    Payment.
      The
      outstanding principal balance, together with any and all accrued unpaid interest
      and any other amounts due and owing under this Note, shall be due and payable
      on
      the date (the ?Maturity Date?) that is the earlier of:

    
      	 	
              A.

            	
              The
                date that Sequiam Corporation receives financing from Instream Capital,
                LLC in an amount greater than $3,000,000 and in turn pays its debt
                to
                Constellation, or;

            

    

    
      	 	
              B.

            	
              If
                Sequiam Corporation does not close new financing on or before May
                10, 2005
                then it will repay its indebtedness to Constellation using 10% of
                its
                revenues from the sales if its primary products ?BioLock? and ?BioVault?
                and Maker will remit such proceeds to Holder with seven (7) days
                of
                receipt.

            

    

    

    All
      payments hereunder shall be due and payable in lawful money of the United States
      of America and without setoff, deduction or counterclaim of any kind whatsoever.
      Unless otherwise specifically provided herein, all payments hereon shall be
      applied first to interest and then to principal.

     

    3.    Warrants.
      Upon
      receipt of the principal amount of this Note, Maker may lend all or part of
      the
      loan proceeds to Sequiam Corporation. Sequiam. In consideration of such loan
      Sequiam Corporation shall issue to Constellation a warrant (the ?Warrant?)
      to
      purchase Six Hundred Thousand (600,000) shares of common stock of Maker at
      a
      purchase price of $0.33 per share, at any time during the "Exercise Period"
      (defined below). As used herein, the "Exercise Period" shall mean the period
      beginning on March 23, 2005 and expiring on March 23, 2010.
      At such
      time that Sequiam Corporation repays its debt to Laurus Master Fund, the Warrant
      will be amended to reduce the purchase price of the shares to $0.14 per share.
      Maker shall assign this Warrant to Holder in consideration of this
      loan.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    4.    Prepayment.
      Maker
      may at any time prepay this Note, in whole or in part, without fee, charge,
      premium or penalty. Holder shall apply payments to the outstanding principal,
      interest and other amounts due hereunder in any manner determined, in Holder's
      sole and absolute discretion.

    

    5.    Disbursements.
      Loan
      proceeds of $200,000 will be disbursed on March 23, 2005, (the ?Execution
      Date?). 

    

    6.    Use
      of
      Proceeds.
      Loan
      proceeds from the principal amount of this Note will not be used to pay accrued
      officers?
      salaries
      or shareholder loans.

     

    7.    Piggy-back
      Registration Rights.
      In the
      event that from the period beginning on the Execution Date and continuing for
      a
      period of twelve (12) months thereafter, Maker shall file a registration
      statement with the SEC registering the sale or resale of any of Maker's debt
      or
      equity securities, Maker shall also include in such registration statement
      the
      shares of common stock to be issued upon exercise of the warrants as described
      in Section 3
      above.

    

    It
      shall
      be a condition precedent to the obligations of Maker to take any action pursuant
      to this Section 7
      that the
      Holder shall furnish to Maker such information regarding itself, the securities
      held by it, and the intended method of disposition of such securities as shall
      be required to effect the registration of Holder?s common stock.

    

    Maker
      shall bear and pay all expenses incurred in connection with any registration,
      filing or qualification of the common stock with respect to the registrations
      pursuant to the Section 7
      for the
      Holder, including (without limitation) all registration, filing and
      qualification fees, printers? and accounting fees relating or apportionable
      thereto, but excluding underwriting discounts and commissions relating to the
      sale of the common stock.

    

    8.    Collateral.
      Patents
      owned by Maker that are presently collateralized under Maker?s loan agreement
      and secured convertible term note with Laurus Master Fund, Ltd. will be given
      as
      collateral to secure this Promissory Note whenever the Laurus note is satisfied
      and if this Promissory Note remains unpaid at that time.

    

    9.    Terms.
      As long
      as this Note remains outstanding, Maker agrees that: (a) if it enters into
      a
      subsequent debt financing with a non-affiliated third party lender; and (b)
      such
      subsequent debt financing contains terms and conditions which are more favorable
      to the non-affiliated third party lender than the terms and conditions set
      forth
      in this Note (the ?Improved Terms?), then the terms and conditions of this
      Note
      shall, simultaneously with the closing of such subsequent financing, be adjusted
      to reflect the Improved Terms.

    

    10.   Representations
      Regarding Private Placement.
      Holder
      hereby represents and warrants to Maker, with the intent that the Maker will
      rely thereon in making and delivering the Note, the Warrant, and the shares
      of
      common stock to be issued upon the exercise of the Warrant, that as of the
      date
      of this Note and as of each date the Warrant, or any portion thereof, is
      exercised:

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (a)    Accredited
      Investor.
      The
      Holder, and each of the beneficiaries for whom the Holder is purchasing the
      Note
      and the Warrant and the shares of Common Stock to be issued upon the exercise
      of
      the Warrant (collectively, the ?Securities?), is an ?accredited investor? as
      that term is defined in Regulation D promulgated under the Securities Act by
      virtue of being (initial all applicable responses):

    

    
      	
              _____

            	 	
              A
                small business investment company licensed by the U.S. Small Business
                Administration under the Small
                Business Investment Company Act of 1958,

            
	 	 	 
	
              _____

            	 	
              A
                business development company as defined in the Investment
                Company Act of 1940,

            
	 	 	 
	
              _____

            	 	
              A
                national or state-chartered commercial bank, whether acting in an
                individual
                or fiduciary capacity,

            
	 	 	 
	
              _____

            	 	
              An
                insurance company as defined in Section 2(13) of the Securities
                Act,

            
	 	 	 
	
              _____

            	 	
              An
                investment company registered under the Investment
                Company Act of 1940,

            
	 	 	 
	
              _____

            	 	
              An
                employee benefit plan within the meaning of Title I of the
                Employee Retirement Income Security Act of 1974,
                where the investment decision is made by a plan fiduciary, as defined
                in
                Section 3(21) of such Act, which is either a bank, insurance company,
                or
                registered investment advisor, or an employee benefit plan which
                has total
                assets in excess of $5,000,000,

            
	 	 	 
	
              _____

            	 	
              A
                private business development company as defined in Section 202(a)(22)
                of
                the Investment
                Advisors Act of 1940,

            
	 	 	 
	
              _____

            	 	
              An
                organization described in Section 501(c)(3) of the Internal
                Revenue Code,
                a
                corporation or a partnership with total assets in excess of
                $5,000,000,

            
	 	 	 
	
              _____

            	 	
              A
                natural person (as opposed to a corporation, partnership, trust or
                other
                legal entity) whose net worth, or joint net worth together with his/her
                spouse, exceeds $1,000,000,

            
	 	 	 
	
              _____

            	 	
              Any
                trust, with total assets in excess of $5,000,000, not formed for
                the
                specific purpose of acquiring the securities offered, whose purchase
                is
                directed by a sophisticated person as described in Section 506(b)(2)(ii)
                of Regulation D,

            
	 	 	 
	
              _____

            	 	
              A
                natural person (as opposed to a corporation, partnership, trust or
                other
                legal entity) whose individual income was in excess of $200,000 in
                each of
                the two most recent years (or whose joint income with such person's
                spouse
                was at least $300,000 during such years) and who reasonably expects
                an
                income in excess of such amount in the current year, or

            
	 	 	
            
	
              _____

            	 	
              A
                corporation, partnership, trust or other legal entity (as opposed
                to a
                natural person) and
                all
                of
                such entity's equity owners fall into one or more of the categories
                enumerated above;

            

    

    

    (b)    Experience.
      The
      Holder is sufficiently experienced in financial and business matters to be
      capable of evaluating the merits and risks of its investments, and to make
      an
      informed decision relating thereto, and to protect its own interests and that
      of
      its beneficiaries in connection with the purchase of the
      Securities;

    

    (c)    Own
      Account.
      The
      Holder is purchasing the Securities as principal for its own account and that
      of
      its beneficiaries. The Holder is purchasing the Securities for investment
      purposes only and not with an intent or view towards furthering sale or
      distribution (as such term is used in Section 2(11) of the Securities Act)
      thereof, and has not pre-arranged any sale with any other
      purchaser;

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    (d)    Exemption.
      The
      Holder understands that the offer and sale of the Securities is not being
      registered under the Securities Act based on the exemption from registration
      provided by Rule 506 promulgated under Section 4(2) of the Securities Act and
      that the Company is relying on such exemption;

    

    (e)    Importance
      of Representations.
      The
      Holder understands that the Securities are being offered and sold to it in
      reliance on an exemption from the registration requirements of the Securities
      Act, and that the Company is relying upon the truth and accuracy of the
      representations, warranties, agreements, acknowledgments and understandings
      of
      the Holder set forth herein in order to determine the applicability of such
      safe
      harbor and the suitability of the Holder to acquire the Securities;

    

    (f)    No
      Registration.
      The
      Securities have not been registered under the Securities Act and may not be
      transferred, sold, assigned, hypothecated or otherwise disposed of unless such
      transaction is the subject of a registration statement filed with and declared
      effective by the Securities and Exchange Commission (the ?SEC?) or unless an
      exemption from the registration requirements under the Securities Act, such
      as
      Rule 144, is available. The Holder represents and warrants and hereby agrees
      that all offers and sales of the Securities shall be made only pursuant to
      such
      registration or to such exemption from registration;

    

    (g)    Risk.
      The
      Holder acknowledges that the purchase of the Securities involves a high degree
      of risk, is aware of the risks and further acknowledges that it can bear the
      economic risk of the Securities, including the total loss of its
      investment;

    

    (h)    Current
      Information.
      The
      Holder has been furnished with or has acquired copies of all requested
      information concerning the Company, including a copy of the most recent audited
      financial statements of the Company;

    

    (i)    Independent
      Investigation.
      The
      Holder, in making the decision to purchase the Securities, has relied upon
      independent investigations made by it and its purchaser representatives, if
      any,
      and the Holder and such representatives, if any, have prior to any sale to
      it,
      been given access and the opportunity to examine all material contracts and
      documents relating to this offering and an opportunity to ask questions of,
      and
      to receive answers from, the Company or any person acting on its behalf
      concerning the terms and conditions of this offering. The Holder and its
      advisors, if any, have been furnished with access to all materials relating
      to
      the business, finances and operation of the Company and materials relating
      to
      the offer and sale of the Securities which have been requested. The Holder
      and
      its advisors, if any, have received complete and satisfactory answers to any
      such inquiries;

    

    (j)    No
      Recommendation or Endorsement.
      The
      Holder understands that no federal, state or provincial agency has passed on
      or
      made any recommendation or endorsement of the Securities;

    

    (k)   The
      Holder.
      If the
      Holder is a partnership, corporation or trust, the person executing this Note
      on
      its behalf represents and warrants that:

    

    (i)    
he
      or she
      has made due inquiry to determine the truthfulness of the representations and
      warranties made pursuant to this Note, and

    

    (ii)    he
      or she
      is duly authorized (and if the undersigned is a trust, by the trust agreement)
      to make this investment and to enter into and execute this Note on behalf of
      such entity; and

    

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (l)    Non-Affiliate
      Status.
      The
      Holder is not an affiliate of the Company nor is any affiliate of the Holder,
      including any beneficiaries of Holder, an affiliate of the Company.

    

    11.    No
      Waiver.
      No
      delay or omission on the part of Holder in exercising any right or remedy under
      this Note shall operate as a waiver of that right or remedy on any future
      occasion or of any other rights under this Note.

    

    12.    Attorneys
      Fees.
      If
      Holder institutes any collection effort, of any nature whatsoever, for any
      amount due and payable hereunder following and during the occurrence of a
      default, then Maker shall pay to Holder forthwith any and all reasonable costs
      and expenses of collection actually incurred by Holder, including without
      limitation, reasonable attorneys fees, whether or not suit or other action
      or
      proceeding is instituted. 

    

    13.    Usury.
      Notwithstanding any provision of this Note to the contrary, the total liability
      for payments in the nature of interest shall not exceed the limits imposed
      by
      the applicable usury laws of the State of California. If, from any circumstances
      whatsoever, fulfillment of any provision hereof or of any other agreement,
      evidencing or securing the debt, at the time performance of such provisions
      shall be due, shall involve the payment of interest in excess of that authorized
      by law, and if from any circumstances, Holder shall ever receive as interest
      an
      amount which would exceed the highest lawful rate applicable to the Maker,
      such
      amount which would be excessive interest shall be applied to the reduction
      of
      the principal balance of the debt evidenced hereby and not to the payment of
      interest.

    

    14.    Severability.
      The
      provisions of this Note are intended by Maker to be severable and divisible
      and
      the invalidity or unenforceability of a provision or term herein shall not
      invalidate or render unenforceable the remainder of this Note or any part
      thereof.

    

    15.    Amendments.
      The
      obligations of Maker and rights of Holder under this Note may be waived,
      altered, amended, modified, or cancelled, in whole or in part, only by the
      express written consent of Holder.

    

    16.    Transferability.
      This
      Note is not transferable prior to the Maturity Date and thereafter without
      Maker?s prior written consent.

    

    17.    Governing
      Law.
      This
      Note shall be governed by and construed and interpreted in accordance with
      the
      internal laws of the State of Florida, without giving effect to any principle
      or
      doctrine regarding conflicts of laws.

    

    IN
      WITNESS WHEREOF, each of Maker and Holder has executed and delivered this Note
      as of the date first written above.

    

    CONSTELLATION
      BIOMETRICS CORPORATION, 

    a
      Florida
      corporation

    

    

    By: 
      /s/
      Mark Mroczkowski

    Mark
      Mroczkowski, Secretary

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

    Maker?s
      Address for Notice:

    Sequiam
      Corporation

    300
      Sunport Lane

    Orlando,
      Florida 32809

    Tel:
      407-541-0773

    Attn:
      Chief Financial Officer

     

    

    /s/
      Lee Harrison Corbin

    LEE
      HARRISON CORBIN, Attorney-in-Fact

    For
      the
      Trust under the will of John Svenningsen

    

    Holder?s
      Address for Notice:

    Kurzman
      Eisenberg Corbin Lever & Goodman, LLP

    One
      North
      Broadway

    White
      Plains, New York 10601

    Tel: 
      914-285-9800

    Attn:
      Lee
      Harrison Corbin, Trustee

     

    6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]